At Wexler Wallace, our driving motivation is to achieve a superior result for our clients. We are prepared to face…
At Wexler Wallace, our driving motivation is to achieve a superior result for our clients. We are prepared to face…
At Wexler Wallace, our driving motivation is to achieve a superior result for our clients. We are prepared to face…
Wexler Wallace LLP is currently investigating claims on behalf of patients who have an IVC filter device and are concerned…
On December 21, 2016, Wexler Wallace Partner Ed Wallace was appointed to the Plaintiffs’ Executive Committee for the coordinated Essure…
Court: United States District Court for the Northern District of Ohio
Jammal, et al. v. American Family Insurance Case No.: 13-cv-00437
Wexler…
Court: United States District Court for the Northern District of Illinois
Case No.: 02-cv-6832
Wexler Wallace filed the complaint and served as…
Court: United States District Court for the Northern District of Illinois
Gomez v. PNC Bank, National Association Case: 1:12-cv-1274
Leadership Position: Lead…
Court: U.S. District Court for the District of Minnesota
Case No.: 0:05-MD-1726 or MDL No. 1726
Wexler Wallace filed suit and served…
Court: United States District Court for the District of Minnesota
Case No.: 0:05-MD-01708 or MDL No. 1708
Wexler Wallace represented numerous personal…
Xarelto (rivaroxaban) is one of a new class of anticoagulants (blood thinners) called direct factor Xa inhibitors manufactured by Janssen…
Court: United States District Court for the District of Rhode Island
In re Kugel Mesh Hernia Patch Products Liability Litigation, Case…
Court: United States District Court for the Northern District of Illinois
In re Testosterone Replacement Therapy Products Liability Litigation, Case No.:…
In 2013, Johnson & Johnson introduced the diabetes drug Invokana to the market. Invokana was the first member of a…
Government payors were excluded from the $350,000,000 settlement with McKesson Corp. in which Wexler Wallace was Co-Lead Counsel. In May…